Global Nuclear Medicine-Radiopharmaceuticals Market Research Report 2014-2026 of Major Types, Applications and Competitive Vendors in Top Regions and Countries
SKU ID :Maia-14624016 | Published Date: 24-Oct-2019 | No. of pages: 112Description
TOC
1 Market Overview
1.1 Nuclear Medicine-Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Diagnostic Medicine
1.2.2 Therapeutic Medicine
1.3 Market Analysis by Application
1.3.1 SPECT
1.3.2 PET
1.3.3 Therapeutic
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2014-2026F)
1.4.2 Europe Market States and Outlook (2014-2026F)
1.4.3 China Market States and Outlook (2014-2026F)
1.4.4 Japan Market States and Outlook (2014-2026F)
1.4.5 Southeast Asia Market States and Outlook (2014-2026F)
1.4.6 India Market States and Outlook (2014-2026F)
1.4.7 Brazil Market States and Outlook (2014-2026F)
1.4.8 GCC Countries Market States and Outlook (2014-2026F)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026
1.6.1 Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Consumption Volume
1.6.2 Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Value
1.6.3 Global Nuclear Medicine-Radiopharmaceuticals Price Trends Analysis from 2014 to 2026
2 Global Nuclear Medicine-Radiopharmaceuticals Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Type
2.1.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Type (2014-2019)
2.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
2.2 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Application
2.2.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2014-2019)
2.2.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Application (2014-2019)
2.3 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Region
2.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Region (2014-2019)
2.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Region (2014-2019)
3 United States Nuclear Medicine-Radiopharmaceuticals Market Analysis
3.1 United States Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
3.2 United States Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
3.3 United States Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
4 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis
4.1 Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
4.2 Europe Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
4.3 Europe Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
4.4 Europe Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries
4.4.1 Germany Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
4.4.2 UK Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
4.4.3 France Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
4.4.4 Italy Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
4.4.5 Spain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
4.4.6 Poland Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
4.4.7 Russia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
5 China Nuclear Medicine-Radiopharmaceuticals Market Analysis
5.1 China Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
5.2 China Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
5.3 China Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
6 Japan Nuclear Medicine-Radiopharmaceuticals Market Analysis
6.1 Japan Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
6.2 Japan Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
6.3 Japan Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Analysis
7.1 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
7.2 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
7.3 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
7.4 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries
7.4.1 Indonesia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
7.4.2 Thailand Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
7.4.3 Philippines Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
7.4.4 Malaysia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
7.4.5 Singapore Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
7.4.6 Vietnam Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
8 India Nuclear Medicine-Radiopharmaceuticals Market Analysis
8.1 India Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
8.2 India Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
8.3 India Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
9 Brazil Nuclear Medicine-Radiopharmaceuticals Market Analysis
9.1 Brazil Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
9.2 Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
9.3 Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
10 GCC Countries Nuclear Medicine-Radiopharmaceuticals Market Analysis
10.1 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis
10.2 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
10.3 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
10.4 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Major Countries
10.4.1 Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
10.4.2 United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
10.4.3 Qatar Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
10.4.4 Bahrain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
11 Manufacturers Profiles
11.1 Siemens Healthcare (US)
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.1.4 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.2 Actinium Pharmaceuticals Inc (US)
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.2.4 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.3 Cardinal Health, Inc (US)
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.3.4 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.4 Jubilant Pharma (India)
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.4.4 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.5 Positron Corporation (US)
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.5.4 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.6 Alliance Medical (UK)
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.6.4 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.7 Peregrine Pharmaceuticals, Inc. (US)
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.7.4 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.8 GE Healthcare (UK)
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.8.4 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.9 Triad Isotopes, Inc. (US)
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.9.4 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.10 Ion Beam Applications S.A (Belgium)
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.10.4 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.11 Bracco Imaging S.p.A (Italy)
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.11.4 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.12 Medi-Radiopharma Ltd (Hungary)
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.12.4 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.13 Lantheus Medical Imaging Inc (US)
11.13.1 Business Overview
11.13.2 Products Analysis
11.13.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.13.4 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.14 Immunomedics, Inc. (US)
11.14.1 Business Overview
11.14.2 Products Analysis
11.14.3 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.14.4 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.15 Alseres Pharmaceuticals, Inc (US)
11.15.1 Business Overview
11.15.2 Products Analysis
11.15.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.15.4 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.16 Avid Radiopharmaceuticals (US)
11.16.1 Business Overview
11.16.2 Products Analysis
11.16.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.16.4 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.17 Mallinckrodt Pharmaceuticals (Ireland)
11.17.1 Business Overview
11.17.2 Products Analysis
11.17.3 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.17.4 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.18 Advanced Medical Isotope Corporation (US)
11.18.1 Business Overview
11.18.2 Products Analysis
11.18.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.18.4 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.19 Bayer HealthCare Medical Care (US)
11.19.1 Business Overview
11.19.2 Products Analysis
11.19.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.19.4 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region
11.20 Nordion, Inc. (Canada)
11.20.1 Business Overview
11.20.2 Products Analysis
11.20.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin
11.20.4 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales by Region
12 Marketing Strategy Analysis
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast (2019-2026)
13.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast (2019-2026)
13.1.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast (2019-2026)
13.1.2 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
13.1.3 Global Nuclear Medicine-Radiopharmaceuticals Price and Trend Forecast (2019-2026)
13.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume, Value and Growth Rate Forecast by Region (2019-2026)
13.2.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast by Region (2019-2026)
13.2.2 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast by Region (2019-2026)
13.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast by Type (2019-2026)
13.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Type (2019-2026)
13.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue Forecast by Type (2019-2026)
13.3.3 Global Nuclear Medicine-Radiopharmaceuticals Price Forecast by Type (2019-2026)
13.4 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume Forecast by Application (2019-2026)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
Tables & Figures
List of Tables and Figures
Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate Segment by Region 2014-2026F
Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate Segment by Product Type from 2014-2026F
Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate Segment by Application 2014-2026F
Figure Nuclear Medicine-Radiopharmaceuticals Picture
Table Product Specifications of Nuclear Medicine-Radiopharmaceuticals
Figure Global Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2018
Table Types of Nuclear Medicine-Radiopharmaceuticals
Figure Diagnostic Medicine Picture
Figure Therapeutic Medicine Picture
Figure Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application in 2018
Table Application of Nuclear Medicine-Radiopharmaceuticals
Figure SPECT Picture
Figure PET Picture
Figure Therapeutic Picture
Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure France Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Poland Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure China Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Thailand Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Philippines Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Singapore Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure India Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Qatar Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F)
Table Emerging and Growing Market of Nuclear Medicine-Radiopharmaceuticals
Table Industry Limitations
Table Opportunities and Development Trends
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Consumption Volume
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Value
Figure Global Nuclear Medicine-Radiopharmaceuticals Price Trends Analysis from 2014 to 2026
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Type (2014-2019)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2014-2019)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Application (2014-2019)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Application (2014-2019)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Region (2014-2019)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Region (2014-2019)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Region (2014-2019)
Figure United States Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table United States Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table United States Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Figure Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table Europe Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table Europe Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Table Europe Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries
Figure Germany Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure UK Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure France Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Italy Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Spain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Poland Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Russia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure China Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure China Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure China Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table China Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table China Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries
Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Thailand Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Philippines Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Singapore Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure India Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure India Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure India Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table India Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table India Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019)
Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019)
Table GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type
Table GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application
Table GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Major Countries
Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Qatar Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019
Table Siemens Healthcare (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Actinium Pharmaceuticals Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Cardinal Health, Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Jubilant Pharma (India) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Positron Corporation (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Alliance Medical (UK) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Peregrine Pharmaceuticals, Inc. (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table GE Healthcare (UK) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Triad Isotopes, Inc. (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Ion Beam Applications S.A (Belgium) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Bracco Imaging S.p.A (Italy) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Medi-Radiopharma Ltd (Hungary) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Lantheus Medical Imaging Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Immunomedics, Inc. (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Alseres Pharmaceuticals, Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Avid Radiopharmaceuticals (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Mallinckrodt Pharmaceuticals (Ireland) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Advanced Medical Isotope Corporation (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Bayer HealthCare Medical Care (US) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Table Nordion, Inc. (Canada) Sales, Price, Revenue, Gross Margin (2014-2019)
Figure Company Sales and Growth Rate
Figure Company Revenue ($) Market Share 2014-2019
Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region
Table Company Basic Information, Manufacturing Base
Table Products Analysis
Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast (2019-2026)
Figure Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Global Nuclear Medicine-Radiopharmaceuticals Price and Trend Forecast (2019-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume Forecast by Region (2019-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Value Forecast by Region (2019-2026)
Figure United States Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure United States Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Germany Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure UK Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure UK Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure France Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure France Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Poland Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Poland Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure China Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure China Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Thailand Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Thailand Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Philippines Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Philippines Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Singapore Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Singapore Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure India Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure India Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Qatar Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Qatar Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026)
Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Type (2019-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Forecast by Type (2019-2026)
Figure Global Nuclear Medicine-Radiopharmaceuticals Price Forecast by Type (2019-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume Forecast by Application (2019-2026)
Companies
- PRICE
-
$3960$5600